Sarah Milla
Concepts (303)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiology | 9 | 2025 | 174 | 1.860 |
Why?
| | Tuberous Sclerosis | 5 | 2014 | 56 | 1.280 |
Why?
| | Pediatrics | 7 | 2025 | 1125 | 1.240 |
Why?
| | Diagnostic Imaging | 6 | 2025 | 337 | 1.000 |
Why?
| | Magnetic Resonance Imaging | 20 | 2024 | 3915 | 0.990 |
Why?
| | Pelvis | 3 | 2025 | 125 | 0.890 |
Why?
| | Neuroimaging | 4 | 2024 | 300 | 0.820 |
Why?
| | Abnormalities, Multiple | 3 | 2022 | 199 | 0.780 |
Why?
| | Radiation Dosage | 4 | 2025 | 193 | 0.730 |
Why?
| | Health Expenditures | 1 | 2024 | 194 | 0.720 |
Why?
| | Medicine | 1 | 2023 | 125 | 0.690 |
Why?
| | Osteogenesis Imperfecta | 1 | 2021 | 14 | 0.690 |
Why?
| | Radiography, Abdominal | 3 | 2018 | 44 | 0.650 |
Why?
| | Education, Medical, Undergraduate | 1 | 2023 | 208 | 0.640 |
Why?
| | Radiography, Thoracic | 2 | 2021 | 172 | 0.630 |
Why?
| | Contrast Media | 6 | 2020 | 497 | 0.630 |
Why?
| | Pyloric Stenosis, Hypertrophic | 1 | 2020 | 10 | 0.630 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2021 | 95 | 0.620 |
Why?
| | Child Abuse | 3 | 2021 | 553 | 0.620 |
Why?
| | Ultrasonography | 6 | 2025 | 788 | 0.610 |
Why?
| | Fetus | 2 | 2022 | 804 | 0.600 |
Why?
| | Diagnosis, Differential | 11 | 2021 | 1512 | 0.590 |
Why?
| | Vitamin D Deficiency | 1 | 2021 | 190 | 0.590 |
Why?
| | Limb Deformities, Congenital | 1 | 2019 | 22 | 0.570 |
Why?
| | Portal Vein | 1 | 2020 | 117 | 0.570 |
Why?
| | Child | 41 | 2026 | 22739 | 0.560 |
Why?
| | Anemia, Sickle Cell | 2 | 2024 | 318 | 0.550 |
Why?
| | Infarction | 1 | 2018 | 9 | 0.550 |
Why?
| | Hematoma, Epidural, Cranial | 1 | 2018 | 6 | 0.550 |
Why?
| | Vascular Malformations | 1 | 2019 | 52 | 0.550 |
Why?
| | Unnecessary Procedures | 1 | 2018 | 54 | 0.530 |
Why?
| | Vitamin D | 1 | 2021 | 404 | 0.530 |
Why?
| | Brain | 8 | 2022 | 2969 | 0.510 |
Why?
| | Infant | 24 | 2026 | 10090 | 0.510 |
Why?
| | Astrocytoma | 5 | 2024 | 130 | 0.500 |
Why?
| | Tomography, X-Ray Computed | 9 | 2023 | 2770 | 0.490 |
Why?
| | Diffusion Tensor Imaging | 2 | 2013 | 78 | 0.470 |
Why?
| | Burnout, Professional | 1 | 2023 | 488 | 0.470 |
Why?
| | Infant, Newborn | 15 | 2022 | 6464 | 0.460 |
Why?
| | Bone and Bones | 1 | 2018 | 318 | 0.440 |
Why?
| | Humans | 69 | 2026 | 145763 | 0.440 |
Why?
| | Models, Neurological | 2 | 2014 | 250 | 0.440 |
Why?
| | Child, Preschool | 23 | 2026 | 11868 | 0.430 |
Why?
| | Lower Extremity | 1 | 2019 | 450 | 0.430 |
Why?
| | Physicians | 1 | 2023 | 956 | 0.410 |
Why?
| | Echo-Planar Imaging | 1 | 2013 | 24 | 0.400 |
Why?
| | Digestive System Diseases | 1 | 2013 | 28 | 0.400 |
Why?
| | Neonatology | 2 | 2024 | 33 | 0.380 |
Why?
| | Respiration | 1 | 2013 | 207 | 0.370 |
Why?
| | Abdomen | 1 | 2013 | 142 | 0.370 |
Why?
| | Societies, Medical | 7 | 2021 | 900 | 0.370 |
Why?
| | Cerebellar Diseases | 1 | 2012 | 27 | 0.360 |
Why?
| | Adolescent | 25 | 2026 | 22573 | 0.360 |
Why?
| | Prenatal Diagnosis | 1 | 2014 | 196 | 0.360 |
Why?
| | Movement Disorders | 1 | 2012 | 69 | 0.350 |
Why?
| | Practice Patterns, Physicians' | 2 | 2018 | 1372 | 0.340 |
Why?
| | Hyperemia | 1 | 2011 | 49 | 0.330 |
Why?
| | Pelvic Pain | 1 | 2011 | 42 | 0.330 |
Why?
| | Endometriosis | 1 | 2011 | 58 | 0.330 |
Why?
| | Cerebellum | 1 | 2012 | 224 | 0.320 |
Why?
| | Brain Mapping | 1 | 2013 | 542 | 0.320 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 1 | 2014 | 235 | 0.320 |
Why?
| | Job Description | 1 | 2010 | 10 | 0.310 |
Why?
| | Female | 37 | 2026 | 79035 | 0.310 |
Why?
| | Brain Neoplasms | 5 | 2024 | 1331 | 0.310 |
Why?
| | Lung | 2 | 2021 | 4116 | 0.310 |
Why?
| | Retrospective Studies | 17 | 2025 | 17325 | 0.300 |
Why?
| | Quality Improvement | 3 | 2026 | 1296 | 0.300 |
Why?
| | Evidence-Based Medicine | 7 | 2021 | 740 | 0.290 |
Why?
| | Gait | 1 | 2012 | 312 | 0.290 |
Why?
| | Male | 34 | 2026 | 73003 | 0.280 |
Why?
| | Workload | 1 | 2010 | 169 | 0.270 |
Why?
| | Hospitals, Pediatric | 3 | 2026 | 558 | 0.270 |
Why?
| | Urography | 1 | 2007 | 19 | 0.270 |
Why?
| | Appendicitis | 2 | 2023 | 150 | 0.260 |
Why?
| | Hypospadias | 1 | 2007 | 31 | 0.260 |
Why?
| | Hypertrophy | 2 | 2020 | 128 | 0.250 |
Why?
| | Curriculum | 2 | 2024 | 1074 | 0.240 |
Why?
| | Imaging, Three-Dimensional | 2 | 2025 | 583 | 0.240 |
Why?
| | Practice Guidelines as Topic | 2 | 2020 | 1582 | 0.230 |
Why?
| | United States | 13 | 2026 | 16123 | 0.220 |
Why?
| | Radiation Monitoring | 1 | 2025 | 16 | 0.220 |
Why?
| | Ventriculoperitoneal Shunt | 2 | 2015 | 44 | 0.220 |
Why?
| | Fluoroscopy | 4 | 2025 | 180 | 0.210 |
Why?
| | Reproducibility of Results | 7 | 2024 | 3416 | 0.210 |
Why?
| | Adrenoleukodystrophy | 1 | 2024 | 9 | 0.210 |
Why?
| | Humanities | 1 | 2023 | 8 | 0.200 |
Why?
| | Phenylurea Compounds | 2 | 2014 | 119 | 0.200 |
Why?
| | Niacinamide | 2 | 2014 | 104 | 0.200 |
Why?
| | Radiologists | 2 | 2021 | 61 | 0.190 |
Why?
| | Sensitivity and Specificity | 6 | 2024 | 2000 | 0.180 |
Why?
| | Incidental Findings | 2 | 2020 | 81 | 0.180 |
Why?
| | Esophagus | 1 | 2024 | 262 | 0.180 |
Why?
| | White Matter | 2 | 2014 | 155 | 0.180 |
Why?
| | Radiography | 2 | 2021 | 853 | 0.180 |
Why?
| | Symporters | 1 | 2022 | 48 | 0.180 |
Why?
| | Age Determination by Skeleton | 1 | 2021 | 16 | 0.170 |
Why?
| | Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2021 | 22 | 0.170 |
Why?
| | Patient Advocacy | 1 | 2022 | 73 | 0.170 |
Why?
| | Cerebrovascular Circulation | 1 | 2024 | 290 | 0.170 |
Why?
| | Empathy | 1 | 2023 | 181 | 0.170 |
Why?
| | Radiation Protection | 2 | 2013 | 41 | 0.170 |
Why?
| | Rickets | 1 | 2021 | 8 | 0.170 |
Why?
| | Leukomalacia, Periventricular | 1 | 2020 | 9 | 0.160 |
Why?
| | Cerebral Intraventricular Hemorrhage | 1 | 2020 | 6 | 0.160 |
Why?
| | Spinal Dysraphism | 1 | 2022 | 110 | 0.160 |
Why?
| | Infectious Encephalitis | 1 | 2020 | 2 | 0.160 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2021 | 122 | 0.160 |
Why?
| | Headache | 2 | 2020 | 151 | 0.160 |
Why?
| | Ovarian Diseases | 1 | 2020 | 14 | 0.160 |
Why?
| | Teratoma | 1 | 2021 | 124 | 0.160 |
Why?
| | Point-of-Care Systems | 1 | 2022 | 189 | 0.160 |
Why?
| | Ileal Diseases | 1 | 2020 | 14 | 0.160 |
Why?
| | Intussusception | 1 | 2020 | 26 | 0.160 |
Why?
| | Wrist | 1 | 2021 | 60 | 0.160 |
Why?
| | Gases | 1 | 2020 | 46 | 0.160 |
Why?
| | Ovariectomy | 1 | 2020 | 166 | 0.150 |
Why?
| | Artificial Intelligence | 2 | 2021 | 381 | 0.150 |
Why?
| | Proteus Syndrome | 1 | 2019 | 1 | 0.150 |
Why?
| | Sturge-Weber Syndrome | 1 | 2019 | 2 | 0.150 |
Why?
| | Dysautonomia, Familial | 1 | 2019 | 2 | 0.150 |
Why?
| | Klippel-Trenaunay-Weber Syndrome | 1 | 2019 | 5 | 0.150 |
Why?
| | Cerebrovascular Disorders | 1 | 2020 | 105 | 0.150 |
Why?
| | Scoliosis | 2 | 2019 | 221 | 0.150 |
Why?
| | Musculoskeletal Abnormalities | 1 | 2019 | 14 | 0.150 |
Why?
| | Lipoma | 1 | 2019 | 17 | 0.140 |
Why?
| | Education, Medical, Graduate | 1 | 2024 | 562 | 0.140 |
Why?
| | Trigeminal Nerve | 1 | 2019 | 27 | 0.140 |
Why?
| | Nevus | 1 | 2019 | 26 | 0.140 |
Why?
| | Oxygen | 1 | 2024 | 981 | 0.140 |
Why?
| | Leadership | 1 | 2023 | 402 | 0.140 |
Why?
| | Spinal Injuries | 1 | 2019 | 60 | 0.140 |
Why?
| | Encephalitis | 1 | 2020 | 142 | 0.140 |
Why?
| | Ovary | 1 | 2020 | 234 | 0.140 |
Why?
| | Syndrome | 1 | 2019 | 381 | 0.130 |
Why?
| | Craniocerebral Trauma | 1 | 2020 | 179 | 0.130 |
Why?
| | Dental Clinics | 1 | 2017 | 6 | 0.130 |
Why?
| | Career Choice | 1 | 2020 | 235 | 0.130 |
Why?
| | Pediatric Dentistry | 1 | 2017 | 12 | 0.130 |
Why?
| | Internal Capsule | 2 | 2014 | 9 | 0.130 |
Why?
| | Wounds and Injuries | 1 | 2026 | 962 | 0.130 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2020 | 534 | 0.120 |
Why?
| | RNA, Viral | 1 | 2020 | 692 | 0.120 |
Why?
| | Sinusitis | 1 | 2018 | 227 | 0.120 |
Why?
| | Fibrosarcoma | 1 | 2015 | 23 | 0.110 |
Why?
| | Sarcoma, Synovial | 1 | 2015 | 20 | 0.110 |
Why?
| | Histiocytosis, Sinus | 1 | 2015 | 7 | 0.110 |
Why?
| | Ovarian Neoplasms | 1 | 2021 | 595 | 0.110 |
Why?
| | Incidence | 2 | 2020 | 2933 | 0.110 |
Why?
| | Heart Neoplasms | 1 | 2015 | 56 | 0.110 |
Why?
| | Mycobacterium Infections | 1 | 2015 | 55 | 0.110 |
Why?
| | Ascites | 1 | 2014 | 48 | 0.110 |
Why?
| | Neurofibromatosis 1 | 1 | 2015 | 57 | 0.100 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2015 | 100 | 0.100 |
Why?
| | Lymphatic Diseases | 1 | 2014 | 21 | 0.100 |
Why?
| | Parotid Gland | 1 | 2014 | 17 | 0.100 |
Why?
| | Pandemics | 1 | 2023 | 1711 | 0.100 |
Why?
| | Young Adult | 5 | 2021 | 14251 | 0.100 |
Why?
| | Disease Outbreaks | 1 | 2017 | 419 | 0.100 |
Why?
| | External Capsule | 1 | 2013 | 3 | 0.100 |
Why?
| | Seizures | 2 | 2021 | 485 | 0.100 |
Why?
| | Anisotropy | 1 | 2013 | 74 | 0.100 |
Why?
| | Brain Diseases | 1 | 2015 | 155 | 0.100 |
Why?
| | Gonads | 1 | 2013 | 22 | 0.100 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2013 | 627 | 0.100 |
Why?
| | Intensive Care, Neonatal | 1 | 2013 | 43 | 0.090 |
Why?
| | Aspartic Acid | 1 | 2013 | 88 | 0.090 |
Why?
| | Gray Matter | 1 | 2013 | 92 | 0.090 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2017 | 339 | 0.090 |
Why?
| | Caudate Nucleus | 1 | 2012 | 22 | 0.090 |
Why?
| | Radiographic Image Enhancement | 2 | 2009 | 57 | 0.090 |
Why?
| | Cerebral Ventricles | 1 | 2012 | 56 | 0.090 |
Why?
| | Brain Diseases, Metabolic, Inborn | 1 | 2011 | 6 | 0.090 |
Why?
| | Polycystic Ovary Syndrome | 1 | 2014 | 188 | 0.090 |
Why?
| | Leukoencephalopathies | 1 | 2011 | 24 | 0.090 |
Why?
| | Attitude of Health Personnel | 1 | 2020 | 1197 | 0.080 |
Why?
| | Neonatal Screening | 1 | 2013 | 179 | 0.080 |
Why?
| | Forensic Medicine | 1 | 2011 | 19 | 0.080 |
Why?
| | Salivary Glands, Minor | 1 | 2011 | 10 | 0.080 |
Why?
| | Age of Onset | 1 | 2013 | 557 | 0.080 |
Why?
| | Expert Testimony | 1 | 2011 | 43 | 0.080 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 297 | 0.080 |
Why?
| | Lung Diseases | 1 | 2017 | 782 | 0.080 |
Why?
| | Salivary Gland Neoplasms | 1 | 2011 | 39 | 0.080 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2011 | 52 | 0.080 |
Why?
| | Myocardium | 1 | 2015 | 935 | 0.080 |
Why?
| | Kidney Diseases | 1 | 2014 | 426 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1217 | 0.070 |
Why?
| | Vesico-Ureteral Reflux | 1 | 2009 | 38 | 0.070 |
Why?
| | Georgia | 2 | 2020 | 79 | 0.070 |
Why?
| | Emergency Service, Hospital | 2 | 2026 | 2383 | 0.070 |
Why?
| | Mutation | 2 | 2024 | 4090 | 0.070 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2015 | 688 | 0.070 |
Why?
| | Pilot Projects | 2 | 2024 | 1897 | 0.070 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2013 | 782 | 0.070 |
Why?
| | Urologic Surgical Procedures, Male | 1 | 2007 | 35 | 0.070 |
Why?
| | Magnetics | 1 | 2007 | 46 | 0.060 |
Why?
| | Intestinal Perforation | 1 | 2007 | 46 | 0.060 |
Why?
| | Multiple Trauma | 1 | 2007 | 121 | 0.060 |
Why?
| | Foreign Bodies | 1 | 2007 | 110 | 0.060 |
Why?
| | Adult | 5 | 2021 | 40872 | 0.060 |
Why?
| | Longitudinal Studies | 1 | 2012 | 2967 | 0.050 |
Why?
| | Benzaldehydes | 1 | 2024 | 11 | 0.050 |
Why?
| | New York | 2 | 2015 | 128 | 0.050 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2024 | 70 | 0.050 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2024 | 72 | 0.050 |
Why?
| | Injury Severity Score | 1 | 2026 | 599 | 0.050 |
Why?
| | Pyrazines | 1 | 2024 | 94 | 0.050 |
Why?
| | Reference Values | 1 | 2024 | 798 | 0.050 |
Why?
| | Inflammation | 1 | 2014 | 2883 | 0.050 |
Why?
| | Neonatologists | 1 | 2022 | 11 | 0.050 |
Why?
| | Trauma Centers | 1 | 2026 | 466 | 0.050 |
Why?
| | Antineoplastic Agents | 1 | 2014 | 2219 | 0.050 |
Why?
| | Hemizygote | 1 | 2022 | 6 | 0.050 |
Why?
| | Prognosis | 3 | 2020 | 4329 | 0.050 |
Why?
| | Maternal Inheritance | 1 | 2022 | 15 | 0.050 |
Why?
| | Loss of Function Mutation | 1 | 2022 | 45 | 0.050 |
Why?
| | Postoperative Complications | 2 | 2020 | 2977 | 0.040 |
Why?
| | Biopsy | 2 | 2015 | 1082 | 0.040 |
Why?
| | Catalytic Domain | 1 | 2022 | 234 | 0.040 |
Why?
| | Obesity | 1 | 2014 | 3118 | 0.040 |
Why?
| | Spine | 1 | 2022 | 182 | 0.040 |
Why?
| | Wrist Joint | 1 | 2021 | 71 | 0.040 |
Why?
| | Mutation, Missense | 1 | 2022 | 335 | 0.040 |
Why?
| | Air | 1 | 2020 | 44 | 0.040 |
Why?
| | Enema | 1 | 2020 | 46 | 0.040 |
Why?
| | Pyrazoles | 1 | 2024 | 517 | 0.040 |
Why?
| | Cerebrospinal Fluid | 1 | 2020 | 88 | 0.040 |
Why?
| | Blood | 1 | 2020 | 107 | 0.040 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2021 | 229 | 0.040 |
Why?
| | Spinal Cord | 1 | 2022 | 382 | 0.040 |
Why?
| | Diagnostic Tests, Routine | 1 | 2020 | 107 | 0.040 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2022 | 293 | 0.040 |
Why?
| | Treatment Outcome | 4 | 2015 | 11793 | 0.040 |
Why?
| | Prospective Studies | 2 | 2021 | 8075 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2019 | 318 | 0.030 |
Why?
| | Pulpotomy | 1 | 2017 | 3 | 0.030 |
Why?
| | Phosphorylation | 1 | 2022 | 1708 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 2 | 2014 | 981 | 0.030 |
Why?
| | Facial Nerve Diseases | 1 | 2017 | 8 | 0.030 |
Why?
| | Tuberculosis, Lymph Node | 1 | 2017 | 7 | 0.030 |
Why?
| | Tooth Loss | 1 | 2017 | 27 | 0.030 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2017 | 23 | 0.030 |
Why?
| | Neck | 1 | 2017 | 109 | 0.030 |
Why?
| | Administration, Intravenous | 1 | 2017 | 172 | 0.030 |
Why?
| | Neutropenia | 1 | 2017 | 154 | 0.030 |
Why?
| | Morbidity | 1 | 2017 | 322 | 0.030 |
Why?
| | Family | 1 | 2021 | 685 | 0.030 |
Why?
| | Infant, Premature | 1 | 2020 | 620 | 0.030 |
Why?
| | Mycobacterium abscessus | 1 | 2017 | 110 | 0.030 |
Why?
| | Respiratory Function Tests | 1 | 2017 | 544 | 0.030 |
Why?
| | Osteomyelitis | 1 | 2017 | 146 | 0.030 |
Why?
| | Anti-Bacterial Agents | 2 | 2017 | 1925 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2019 | 5922 | 0.030 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2014 | 47 | 0.030 |
Why?
| | Fibrosis | 1 | 2017 | 561 | 0.030 |
Why?
| | Time Factors | 1 | 2026 | 7133 | 0.030 |
Why?
| | Fatal Outcome | 1 | 2015 | 305 | 0.030 |
Why?
| | Debridement | 1 | 2015 | 85 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 2123 | 0.030 |
Why?
| | Corpus Callosum | 1 | 2014 | 72 | 0.030 |
Why?
| | Neurites | 1 | 2014 | 50 | 0.030 |
Why?
| | Hyperandrogenism | 1 | 2014 | 25 | 0.030 |
Why?
| | Ovarian Follicle | 1 | 2014 | 78 | 0.030 |
Why?
| | NIH 3T3 Cells | 1 | 2014 | 145 | 0.030 |
Why?
| | Review Literature as Topic | 1 | 2014 | 52 | 0.030 |
Why?
| | Hearing Loss | 1 | 2017 | 249 | 0.020 |
Why?
| | Internship and Residency | 1 | 2024 | 1269 | 0.020 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2014 | 156 | 0.020 |
Why?
| | Inositol | 1 | 2013 | 25 | 0.020 |
Why?
| | Axons | 1 | 2014 | 204 | 0.020 |
Why?
| | Creatine | 1 | 2013 | 63 | 0.020 |
Why?
| | Myelin Sheath | 1 | 2014 | 166 | 0.020 |
Why?
| | Echocardiography | 1 | 2015 | 648 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2014 | 308 | 0.020 |
Why?
| | Choline | 1 | 2013 | 138 | 0.020 |
Why?
| | Biomarkers | 2 | 2014 | 4302 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2014 | 971 | 0.020 |
Why?
| | Neurotransmitter Agents | 1 | 2011 | 84 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2015 | 1723 | 0.020 |
Why?
| | Recurrence | 1 | 2014 | 1139 | 0.020 |
Why?
| | Cheek | 1 | 2011 | 16 | 0.020 |
Why?
| | Mouth Mucosa | 1 | 2011 | 85 | 0.020 |
Why?
| | Testosterone | 1 | 2014 | 416 | 0.020 |
Why?
| | Computer Simulation | 1 | 2014 | 1003 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2014 | 1165 | 0.020 |
Why?
| | Survival Rate | 1 | 2015 | 2094 | 0.020 |
Why?
| | Acute Kidney Injury | 1 | 2017 | 874 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2011 | 770 | 0.020 |
Why?
| | Liver | 1 | 2017 | 1899 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2015 | 1329 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2933 | 0.010 |
Why?
| | Insulin Resistance | 1 | 2014 | 1244 | 0.010 |
Why?
| | Body Mass Index | 1 | 2014 | 2447 | 0.010 |
Why?
| | Eating | 1 | 2007 | 387 | 0.010 |
Why?
| | Aging | 1 | 2014 | 1973 | 0.010 |
Why?
| | Insulin | 1 | 2014 | 2516 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2012 | 5428 | 0.010 |
Why?
| | Cohort Studies | 1 | 2012 | 6032 | 0.010 |
Why?
| | Risk Factors | 1 | 2015 | 10917 | 0.010 |
Why?
| | Mice | 1 | 2014 | 18355 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 36302 | 0.010 |
Why?
| | Animals | 1 | 2014 | 38097 | 0.010 |
Why?
|
|
Milla's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|